American Well Co. (NYSE:AMWL) COO Kurt Knight sold 16,233 shares of the business's stock in a transaction on Monday, April 5th. The stock was sold at an average price of $18.02, for a total value of $292,518.66. Following the transaction, the chief operating officer now directly owns 1,185,093 shares in the company, valued at approximately $21,355,375.86. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Kurt Knight also recently made the following trade(s):
- On Wednesday, January 20th, Kurt Knight sold 133,652 shares of American Well stock. The stock was sold at an average price of $26.43, for a total value of $3,532,422.36.
AMWL traded down $0.40 on Wednesday, hitting $16.89. 1,754,893 shares of the company were exchanged, compared to its average volume of 3,587,135. American Well Co. has a twelve month low of $15.53 and a twelve month high of $43.75. The firm has a 50-day moving average price of $22.35 and a two-hundred day moving average price of $26.76.
American Well (NYSE:AMWL) last released its earnings results on Tuesday, March 23rd. The company reported ($0.51) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.26) by ($0.25). The company had revenue of $60.40 million during the quarter, compared to analysts' expectations of $54.60 million. The firm's revenue was up 34.2% compared to the same quarter last year. On average, research analysts anticipate that American Well Co. will post -3.38 earnings per share for the current year.
A number of equities research analysts have commented on the company. BTIG Research initiated coverage on American Well in a research report on Wednesday, January 6th. They issued a "neutral" rating on the stock. Stifel Nicolaus initiated coverage on American Well in a report on Friday, December 18th. They issued a "hold" rating and a $29.00 price objective on the stock. Morgan Stanley cut their price objective on American Well from $33.00 to $32.00 and set an "overweight" rating on the stock in a report on Thursday, April 1st. Credit Suisse Group downgraded American Well from an "outperform" rating to a "neutral" rating and set a $41.00 price objective on the stock. in a report on Wednesday, January 27th. Finally, Piper Sandler lowered their target price on American Well from $45.00 to $30.00 and set an "overweight" rating for the company in a research note on Thursday, March 25th. Seven analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. American Well currently has a consensus rating of "Hold" and an average target price of $33.25.
Several large investors have recently added to or reduced their stakes in the company. American International Group Inc. acquired a new position in shares of American Well during the 4th quarter worth about $25,000. Steward Partners Investment Advisory LLC boosted its position in shares of American Well by 125.0% during the 4th quarter. Steward Partners Investment Advisory LLC now owns 1,800 shares of the company's stock worth $46,000 after acquiring an additional 1,000 shares in the last quarter. Jacobi Capital Management LLC acquired a new position in shares of American Well during the 4th quarter worth about $29,000. CWM LLC acquired a new position in shares of American Well during the 4th quarter worth about $37,000. Finally, Davis Rea LTD. boosted its position in shares of American Well by 9.9% during the 4th quarter. Davis Rea LTD. now owns 18,690 shares of the company's stock worth $473,000 after acquiring an additional 1,690 shares in the last quarter. 18.97% of the stock is owned by institutional investors and hedge funds.
About American Well
American Well Corporation provides a telehealth application that connects and enables providers, insurers, patients, and innovators to deliver access to healthcare. Its application offers urgent care; pediatrics; therapy; menopause nutrition; menopause counseling; telestroke; population health management; telepsychiatry; pregnancy and postpartum nutrition; pregnancy and postpartum therapy; breastfeed support; menopause care; pregnancy and postpartum care; and chromic disease management services.
Further Reading: How prevalent are 12b-1 fees?
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]7 Stocks to Support Your New Year’s Resolutions
After a year like 2020, many Americans figure that just getting to 2021 was enough. But for many people, the start of a new year still means making resolutions. And while many Americans are still waking up to Groundhog’s Day, there is hope that things will look dramatically different in September than they do right now.
Some of the most popular resolutions include losing weight, exercising more, or taking steps to get our life and/or business more organized. And many pure-play companies lean into these trends and are doing well.
As an alternative to this, you can also invest in companies that are not pure plays but can still benefit from consumers looking to start fresh. Owning these stocks helps you manage your risk. If the trend holds, you can ride the wave. On the other hand, if the wave turns into a ripple, the stocks have other catalysts to get them through.
In this special presentation, we’ll take a look at both of these categories. We’ve got several pure-play companies that let investors buy stocks in companies benefiting from these trends. We’ll also give you a few stocks that fall in the latter category.
These are stocks that you might buy at any time and for many reasons. However, they present excellent buys as the new year begins.
View the "7 Stocks to Support Your New Year’s Resolutions"